Prothrombotic genetic risk factors in stroke: a possible different role in pediatric and adult patients

Clin Appl Thromb Hemost. 2012 Nov;18(6):658-61. doi: 10.1177/1076029611432136. Epub 2012 Jan 23.

Abstract

The role of thrombophilia in the pathogenesis of stroke is still controversial, especially in the pediatric stroke. In order to examine the role of common thrombophilic mutations in children and adults with stroke, a case-control study was carried out in a group of 80 children and 73 younger adult patients. The control groups encompassed 100 healthy children and 120 healthy blood donors. Our results showed no significant differences in the frequency of factor V (FV) Leiden, FII G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T variants between patient groups and corresponding controls. According to our results, carriers of 677CT genotype have 3.62 higher risks to develop stroke in children than in adults (P < .001). The obtained data indicate that heterozygosity for MTHFR C677T variant represents a possible important risk factor for pediatric stroke and suggest a different role of this gene variant in etiology of stroke in pediatric and adult patients.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Factor V / genetics*
  • Factor V / metabolism
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / blood
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Middle Aged
  • Mutation*
  • Prothrombin / genetics*
  • Prothrombin / metabolism
  • Risk Factors
  • Stroke / blood
  • Stroke / etiology
  • Stroke / genetics*
  • Thrombophilia / blood
  • Thrombophilia / complications
  • Thrombophilia / genetics

Substances

  • factor V Leiden
  • Factor V
  • Prothrombin
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)